Biberach, Germany

Marcus Schindler

USPTO Granted Patents = 15 


Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 52(Granted Patents)


Location History:

  • Nuneham Courtenay, GB (2016)
  • Biberach, DE (2006 - 2017)
  • Hovås, SE (2019 - 2020)

Company Filing History:


Years Active: 2006-2020

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Innovations by Marcus Schindler: A Look at his Contributions to the Treatment of Obesity

Introduction

Marcus Schindler, an innovative inventor based in Biberach, Germany, has made significant strides in the field of pharmacology with a focus on obesity treatment. With a total of 15 patents to his name, Schindler's work has contributed to advancing medical science, particularly in addressing obesity and its related diseases.

Latest Patents

Among his latest innovations is the patent for the "Use of Flibanserin in the treatment of obesity." This invention details compositions intended for combating obesity and related health issues. It describes a formulation that combines an active substance, distinct from flibanserin itself, which is selected from a group of known obesity treatment agents. Flibanserin is incorporated optionally, often as pharmacologically acceptable acid addition salts. This underscores Schindler's commitment to developing effective treatment options for obesity.

Career Highlights

Marcus Schindler has had a notable career, having collaborated with esteemed organizations in the pharmaceutical industry. He has worked at Boehringer Ingelheim International GmbH and Sprout Pharmaceuticals, Inc., both leading names in medical research and drug development. His contributions in these settings have been fundamental in enhancing treatment modalities for patients worldwide.

Collaborations

Throughout his career, Schindler has had the opportunity to work alongside talented individuals such as Dirk Stenkamp and Stephan Georg Mueller. These collaborations have enriched his inventions and expanded the scope of research in the pharmaceutical sector.

Conclusion

Marcus Schindler stands out as a key inventor in the domain of obesity treatment, with a portfolio of patents that demonstrates his dedication to improving human health. His latest innovations highlight the potential of combining existing treatments with new methodologies, promising better outcomes for obesity management. Schindler's work continues to inspire and pave the way for further research and development in pharmacological treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…